论文著作：
1. Dong T#, Niu H#, Chu Z#, Zhou C, Gao Y, Jia M, Sun B, Zheng X, Zhang W, Zhang J, Luo Y, Sun Y, Wang C, Lu Q, Liu C, Shao G, Lou H*, Yuan H*. Targeting VPS18 hampers retromer trafficking of PD-L1 and augments immunotherapy. Sci. Adv. 2024, 10(42):eadp4917.
2. Dong T#, Hu G#*, Fan Z, Wang H, Gao Y, Wang S, Xu H, Yaffe MB, Vander Heiden MG, Lv G*, and Chen J*. Activation of GPR3-β-arrestin2-PKM2 pathway in Kupffer cells stimulates glycolysis and inhibits obesity and liver pathogenesis. Nat. Commun. 2024, 15(1):807.
3. Zhang W#, Wang M#, Ji C, Liu X, Gu B*, and Dong T*. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials. Biomed. Pharmacother. 2024, 177:116930.
4. Wang H, Gao Y, Wang L, Yu Y,Zhang J, Liu C, Song Y, Xu H, Wang J, Lou H*, Dong T*. Lung specific homing of diphenyleneiodonium chloride improves pulmonary fibrosis by inhibiting macrophage M2 metabolic program. J. Adv. Res. 2023, 44:213-225.
5. Dong T#, Chen X#, Xu H, Song Y, Wang H, Gao Y, Wang J, Du R, Lou H*, and Dong T*. Mitochondrial metabolism mediated macrophage polarization in chronic lung diseases. Pharmacol. Ther. 2022, 239:108208.
6. Li Y#, Ivica N#, Dong T#, Kleyman M, Hu G, Papageorgiou DP, He Y, Chen W, Sullivan LB. Del Rosario A, Hammond PT, Vander Heiden MG, Chen J*. MFSD7C switches mitochondrial ATP synthesis to thermogenesis in response to heme. Nat. Commun. 2020, 11:4837.
发明专利：
1. 授权日期：2024.01.26，Sesquiterpenoids，US patent ，专利申请号：20170044180， Xiaoguang Lei, Chao Li, Ting Dong.
2. 授权日期：2022.03，TARGET FOR MODULATING BODY MASS，US patent, WO/2022/051254，Jianzhu Chen, Nikola Ivica, Yingzhong Li, Ting Dong.
3. 授权日期：2024.01.26，一种肺精准靶向的脂质体纳米粒复合物及其制备方法和应用，中国，专利: CN 115645369B.
董婷
北京市
研究领域：
生物医药
研究方向：
细胞衰老化学生物学
所在单位：
中国医学科学院北京协和医学院
